Niraparib tosylate monohydrate is a tosylate salt form of niraparib which is a PARP-1 and PARP-2 inhibitor and has an effective and powerful antineoplastic activity against ovarian cancer. This evidence concerns the gene PARP1 and ovarian carcinoma.